Page 39 - Pharma Bro News Today

A federal judge has ordered Martin Shkreli to return $64.6 million in profits reaped from inflating the price of a lifesaving drug and barred him from the pharmaceutical industry for

A federal judge has ordered Martin Shkreli to return $64.6 million in profits reaped from inflating the price of a lifesaving drug and barred him from the pharmaceutical industry for

White House: Russia prepping pretext for Ukraine invasion

Martin Shkreli, who is serving a seven-year prison sentence for fraud, must return profits he and his former company reaped from raising the price of a lifesaving drug, a federal judge ruled.

NEW YORK – Martin Shkreli should return $64.6 million in income he and his former firm reaped from jacking up the value and monopolizing the marketplace

Martin Shkreli, who is serving a seven-year prison sentence for fraud, must return profits he and his former company reaped from raising the price of a lifesaving drug, a federal judge ruled.

Martin Shkreli, who is serving a seven-year prison sentence for fraud, must return profits he and his former company reaped from raising the price of a lifesaving drug, a federal judge ruled.

The federal judge also barred Shkreli from participating in the drug industry for the rest of his life.

Martin Shkreli was condemned for raising Daraprim’s price in 2015 by people like Donald Trump and Hillary Clinton.

A federal judge has ordered Martin Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life.